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One approach to investigating the nature of T lymphocyte recognition of  exogenous 
antigens  and  mechanisms  of Ir  gene control  has  used  small,  well-defined  peptide 
antigens. In previous studies we used synthetic homologues and analogues of human 
fibrinopeptide B to examine strain 2 and strain  13 guinea pig T  cell responses and 
found that  Ir gene control correlated with the presence or absence of the carboxyl 
terminal residue, and that responsiveness was determined by macrophage Ia antigens 
(1, 2). In addition, several peptide residues were identified that were responsible for 
the specificity of the T  cell responses, and most likely served as contact residues for 
clonally distributed T  cell antigen-combining receptors (3).  However, these immune 
responses  were  solely  cell  mediated,  and  we  were  unable  to  generate  detectable 
antibody by a  variety of approaches. It was therefore difficult to compare T  and B 
cell  recognition  of the  same  peptide  antigen  to  determine  whether  the  antigen- 
combining repertoire of both cell types was similar. For this reason, we have employed 
the octapeptide hormone angiotensin II (AII) 1 as an antigen system to investigate T 
and B cell recognition. AII has been used previously to investigate the specificity and 
spatial  constraints of antibody binding in several species  (reviewed in reference 4). 
Moreover, Dietrich (5) found that free AII elicited both immediate and delayed-type 
hypersensitivity reactions in guinea pigs. In this study we have extended the findings 
of Dietrich  to examine Ir gene control and  the specificity of T  cell responses to a 
variety of synthetic homologues and analogues of AII in strain 2 and strain  13 guinea 
pigs.  Evidence  is  presented  that  demonstrates  the  exquisite  specificity of Ir  gene 
control of T  cell responses and indicates that the diversity of the antigen recognition 
repertoire in strain 2 and strain  13 animals is generally nonoverlapping. 
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Infectious Diseases  and grant HL-22642  from the National Heart,  Lung, and Blood Institute, National 
Institutes of Health. 
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1  ..........  Abbrevzatwns  used  in  thts  paper."  Ahp,  heptyhne,  L-2-aminoheptanoic  acid;  AI,  angIotensin  I;  AII, 
3  3  angiotensin II  AIII, [des-Asp ]-AII  CFA, complete Freund's adjuvant  [ H]TdR,  [methyl- H]thymidine; 
Ia, I region-associated antigens; Nle,  norleucine, L-2-aminohexanoic acid;  PEL, peritoneal exudate lym- 
phocyte;  Phe(4-NH2), 4-aminophenylalanine; Phe(4-NO2),  4-nitrophenylalanine; PPD,  purified  protein 
derivative of tuberculin; Sar, sarcosine, N-methylglycine. 
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Materials  and Methods 
Animals.  Inbred strain 2 and strain  13 guinea pigs were obtained from Biological Systems, 
Toms River, N. J. 
Antigens.  Synthetic human angiotensin II (AII), [ValS]-AII, [Asn1,ValS]-AII, angiotensin III 
(AIII), [VaI4]-AIII, [IleT]-AIII, angiotensin I  (AI), [Sar~,Alaa]-AII,  [Sarl,Glya]-AII, [Sar~,Ilea]- 
AII, and [Sarl,Leu8]-AII were purchased from Vega-Fox Biochemicals Div., Newberg Energy 
Corp.,  Tucson,  Ariz.  The  analogues  [AcAsnl,ValS,des-Phea]-AII,  [AsnI,Phe(4-NH~)*]-AII, 
[Asn',Phe(4-NH~)n]-AII, [Asn~,Phe(4-NH2)8]-AII,  [Asna,Phe(a-NOa)4]-AII,  [Asnl,Phe(4-NO2)S] - 
AII, [Asna,NieS]-AII, and [Asnl,Ahpa]-AII, were synthesized and purified as described elsewhere 
(6-8).  The primary structure of each peptide  is shown in Fig.  1. The abbreviations used to 
denote amino acids and peptides are those recommended by the International Union of Pure 
and  Applied  Chemistry/International  Union  of Biochemistry Commission  on  Biochemical 
Nomenclature (9). 
Preparation of Cells.  2-6  wk  after  immunization  with  400  #g  of AII or  of the  various 
homologues or analogues in complete Freund's adjuvant  (CFA; Difco Laboratories, Detroit, 
Mich.), guinea pigs were injected intraperitoneally with 25 ml of sterile  mineral oil (Marcol 52; 
Humble  Oil  and  Refining  Co.,  Houston,  Tex.),  and  the  resulting  peritoneal  exudate  was 
harvested 3-4 d later. A T  lymphocyte-enriched peritoneal exudate lymphocyte (PEL) popu- 
lation was prepared by passing cells over a rayon wool adherence column (10). 
In Vitro Assay of DNA Synthesis.  Immune PEL (3-4 ×  105 cells/well) were cultured in round- 
bottom  microtiter  plates  (Cooke  Laboratory  Products  Div.,  Dynatech  Laboratories,  Inc., 
Arlington, Va.) with soluble AII peptide antigens (5-40 #g/well) or purified protein derivative 
of tuberculin (PPD) (10 #g/well), in a total volume of  0.2 ml of RPMI-1640 medium containing 
L-glutamine (300 #g/mi), penicillin (100 U/ml), 2-mercaptoethanol (5 ×  10  -5 M), and 5% heat- 
inactivated normal guinea pig serum. After incubation for 2 d at 37°C in 5% CO2 in air,  1 #Ci 
of tritiated thymidine ([aH]TdR, sp ac 6.7 Ci/mM; Research Products International Corp., Elk 
Grove Village,  Ill.)  was added  to each well,  The amount of radioactivity incorporated  into 
cellular DNA was determined after an additional  18-h incubation with the aid of a semiauto- 
mated  microharvesting  device  (Titer-Tek,  Flow  Laboratories,  Inc.,  Rockville,  Md.).  Each 
[3H]TdR cpm  value  represents  the  mean  of triplicate  cultures  and  the standard  error was 
always within 10% of the mean. The representative experiments shown were each performed 2- 
6  times with similar  results,  and  40 #g of the peptide  antigens was the dose producing the 
highest proliferative responses. 
Results 
Strain  2 and strain  13 guinea pigs were immunized with All or related  analogues 
and  in  vitro  T  cell  proliferative  responses  were  determined  with  the  homologous 
immunizing  antigen  as  well  as  with  other  selected  AII analogues.  A  summary  of 
relative strain 2 and strain  13 T  cell responsiveness, along with the primary sequence 
of AII and each analogue used as antigen, is shown in Fig.  I. Most of these results will 
be  detailed  in  the  tables.  T  cells  from strain  2  animals  immunized  with  AII were 
stimulated  by in vitro culture with AII and  showed little or no responsiveness  with 
[ValS]-AII (Table I). In contrast, T  cells from strain  13 guinea pigs immunized with 
AII were unresponsive with both AII and [ValS]-AII. Reciprocal results were obtained 
after  immunization  with  [ValS]-AII: immune strain  13 T  cells were stimulated  with 
[ValS]-AII but not with AII, and immune strain 2 T  cells showed a  low response with 
[ValS]-AII and  no response  with  AII. These  results  indicate  that  Ir gene control of 
responsiveness  to AII and  [Val~]-AII by strain  2 and strain  13 guinea pigs is specific 
and can discriminate  between  Ile  5 and Val 5 residues,  which differ only by a  methyl 
group. 
The  contribution  of peptide  length  to  T  cell  responsiveness  was  examined  by 
immunization with AI and AIII ([des-Aspl]-AII) (Table II). AIII is shortened by one THOMAS,  HSIEH,  SCHAUSTER,  AND  WILNER 
Immune  response 
Guinea pig 
Strain  2  Strain  13 
All  H2N-Asp  t  Ar~  Val :j  Tyr  4  lie  s  His  n  Pro  7  Phc~-OH  +++  - 
[Valr']-All  Val  +  +++ 
[Asn z, VaI~]-AII  Asn  Val  --  +++ 
[Val't]-Alll  .Val  -  - 
[AcAsn I, Val  ~', des-PheS]-AIl  AcAsn  Val  -  +++ 
AI  His I,eu  ±  +++ 
AIII  -  +++ 
[Ile:[-AIII  Ile  -  - 
[Asn I, Phe(4-NH2)"I-AII  Ash  Phe(4-NH2)  +++  - 
[Asn I, Phe(4-NH2)S]-AI1  Asn  Phe(4-NH2)_  -  +++ 
[Asn I, Phe(4-NH2)aI-AII  Ash  Phe(4-NH,2)  --  +++ 
[Asn t, Phe(4-NO.z)4]-A|I  Ash  Phe(4-NO~)  +++  q-++ 
lash 1, Phe(4-NO.z)S]-All  Asn  Phe(4-NO2)  +++  +++ 
lash ~, NleSI-Al[  Asn  Nle  -  - 
[Asn t, Ahp'*]-All  Asn  Ahp  -  - 
[Sar I, AlaSl-AII  Sat  Ala  -  - 
[Sat  I, GlyS]-AII  Sat  Gly  -  - 
[Sar t, lleS]-All  Sar  lie  --  - 
[Sar I, l..euS]-All  Sar  [~eu  -  - 
Fro.  1.  Primary structure of AII and related homologues and analogues, and summary of antige- 
nicity  and  immunogenicity  of these  peptides  for strain  2  and strain  13 guinea  pig T  lymphocyte 
responses. 
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TABLE I 
Antigenicity and Immunogenicity of AH and [ValS]-AII in Strain 2 and Strain 13 Guinea Pigs 
Guinea  [3H]TdR antigen  in culture* 
pig  Immunized 
strain  None  PPD  AII  [ValS]-AII 
cpm  cpm 
2  AII  1,542  ±  170  119,993 ±  2,577  80,013 ±  2,012  1,464  ±  128 
13  AII  6,695 4- 817  120,533 ±  1,774  7,722 ±  104  6,578 +  268 
2  [ValS]-AII  1,385 ::t: 22  73,299 ::l:: 1,414  1,448 ±  134  6,319 ±  571 
13  [ValS]-AII  4,914 :l: 310  166,970 ±  2,595  5,534 :l: 387  41,190 ±  2,004 
* Strain 2 and strain  13 guinea pigs were immunized  with AII or AII analogues as indicated.  2-6 wk after 
immunization,  T  cell-enriched  PEL  were  cultured  in  vitro  with  PPD,  as  a  positive  control,  and  the 
indicated  AII analogues  (40 #g/well),  as described  in  Materials  and  Methods.  The  [aH]TdR  cpm were 
determined  on the 3rd d  of culture  and each value represents the mean cpm  from  triplicate  cultures ± 
the  standard  error.  Underlined  values  indicate  those  cultures  in  which  positive  stimulation  occurred; 
italics indicate those cultures showing relatively less stimulation. 
TABLE  II 
Immunogenicity and Antigenicity of AI and AIII in Strain 2 and Strain 13 Guinea Pigs 
Guinea 
pig 
strain 
Immunized 
[~HITdR  antigen in culture* 
None  PPI)  AII  AI  AIII 
cpm  cpm  cpm 
2  All  2,627 ±  473  133,767 :t: 5,016  36,249 +  280  4,084 ±  95  4,322 ±  652 
2  AI  1,658 ±  74  120,230 ±  6,411  9.302 ±  1,343  ~,556 ±  735  1,548 ±  151 
2  AIII  2,878 ±  222  176,188 ±  3,539  3,137 ±  272  3,081  ±  189  3,148 ±  332 
13  AI  578 ±  172  124,770 ±  1,798  9,48.9 ±  612  38,007 ±  1,726  3,879 ±  409 
13  AIII  616 ±  61  162,600 ±  8,012  6.370 ±  408  13,61l ±  596  43.841  ±  466 
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residue at the amino terminus, and AI is lengthened by two residues at the carboxyl 
terminus. Strain 2 AII-immune T  cells showed little or no responsiveness with AI and 
AIII, which indicates that despite considerable residue homology, addition or removal 
of residues  from AII  dramatically altered antigenicity.  Moreover, these alterations 
eliminated immunogenicity in strain 2 guinea pigs. Strain 2 animals immunized with 
AI produced a marginal T  cell response with AI, no response with AIII, and showed 
a relatively low response with AII. T  cells from strain 2 guinea pigs immunized with 
AIII were unresponsive to AI, AII, and AIII. In contrast, changing the length of AII 
results in peptides with enhanced immunogenicity in strain  13 guinea pigs. Strain 13 
AI-immune T  cells responded to AI and showed some cross-reactivity with AII and 
AIII. T  cells from AIII-immune strain 13 animals responded with AIII and showed 15 
and  30%  cross-reactivity with  AII  and  AI,  respectively. These results  suggest  that 
genetic control of responsiveness to the AII peptides  may involve multiple peptide 
residues. As shown in Table I, strain  13 guinea pigs responded to [ValS]-AII but not 
to AII, which indicates control of responsiveness by the fifth residue. However, strain 
13  animals  responded  to  [Ile4]-AIII,  as  shown  in  Table  II,  indicating  that  in  this 
instance the first AII residue also appeared to control responsiveness. 
The contributions of the first and fifth AII residues to strain  13 responsiveness to 
[ValS]-AII were further examined using the analogues [Asnl,Val~]-AII and [VaI4]-AIII 
as shown in Table III. T cells from [ValS]-AII-immune strain 13 guinea pigs responded 
to the same extent with [ValS]-AII and [Asna,ValS]-AII, but showed no response with 
[VaI4]-AIII. Similarly, T cells from [Asnl,ValS]-AII-immune animals responded in the 
same way with  [VaI~]-AII  and  [Asnl,ValS]-AII, but  were unresponsive with  [Val4] - 
AIII.  [Val4]-AIII-immune  strain  13  guinea  pigs  showed  no  response  with  either 
[VaI4]-AIII or [Val~]-AII. Therefore, it is clear that  the first residue of [ValS]-AII is 
critical for strain  13 responsiveness, but that there may be little specificity associated 
with  this  position  because  Asp 1 and  Asn 1 are  interchangeable.  In  addition,  the 
presence or  absence of the  first  residue  is  involved in  determining  the  control  of 
responsiveness by the fifth residue. Thus, strain  13 animals respond to [ValS]-AII but 
not to [IleS]-AII;  however, with the removal of Asp 1 (AIII), the animals now respond 
to [Ile4]-AIII only and not to [Val4]-AIII. These results indicate that there is no single 
residue  indicative of Ir gene control, and  that  each peptide analogue  represents  a 
unique antigen, responsiveness to which cannot be predicted. 
The contribution of Tyr  4, His  6, and  Phe  s to Ir gene control and T  cell responses 
was examined using two sets of analogues with substitutions for these residues. In the 
first series, Phe(4-NH2) was substituted for Tyr  4, His  6, or Phe  s, and each analogue was 
tested  for antigenicity and  immunogenicity in  strain  2  and  strain  13  guinea  pigs 
(Table  IV).  T  cells  from  AII-immune  strain  2  animals  showed  no  response  with 
TABLE III 
Role of Asp' in Strain 13 Guinea Pig Responses to [Vala]-All 
Strain  13  [:JHITdR antigen in culture* 
guinea pig 
immunized  None  PPD  [Valn]-All  [Asn l, ValS]-All  [VaI*I-AIII 
[Valnt-AII  4,914 ±  310  166,970 ±  2,595  41,1~) +  2,004  46,378 4, 503  3.878 4. 257 
IAsn I, ValS]-AI[  3,859 ±  106  193,710 ±  6,146  61,370 +  508  62,269 4. 4,038  5.675 ±  725 
[VaI4]-AII[  2,193 ±  69  145,108 "4" 1,234  3,436 4- 547  NI):~  3,636 zt: 323 
* Same as Table 1. 
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TABLe IV 
Antigen±city and Immunogenicity of AIl Analogues in Which  Tyr  4, His  s, and Phe s are Replaced by Phe(4-NH2) 
Guinea 
[SH]TdR antigen in culture* 
pig  Immunized  [Asn ~,  [Asn ~,  [Asn ~, 
strain  None  PPD  All  Phe(4-NH2)4]-  Phe(4-NH~I%  Phe(4-NH2)% 
All  All  All 
epm  cpm  cpm 
2  All  2,627 ±  473  133,767 ±  5,016  36,249 :[: 237  3,476 +  237  2,876 ±  404  2,623 ±  160 
2  [Asn I, Phe(4-NH2)']-AII  2,353 ±  297  180,999 ±  3,736  2,160 ±  104  54,451 ±  4,146  2,216 ±  386  3,972 ±  456 
2  [Asn 1, Phe(4-NH2)6I-AII  1,187 ±  188  146,366 ±  7,052  1,244 ±  75  1,041 ±  259  879 ±  34  987 ±  24 
2  [Asn l, Phe(4-NH2)S]-AII  3,393 ±  69  125,548 ±  964  4,197 ±  429  3,086 ±  1,059  3,282 ±  246  3,184 ±  461 
13  [Asn I, Phe(4-NH2)4I-AII  800 ::l:  87  117,428 ±  4,983  1,219 ±  109  1,566 "+- 203  902 ±  173  1,359 ±  236 
13  [Asn ~, Phe(4-NH2)%AII  3,376 ::[: 129  262,600 ±  12,059  5,304 ±  560  3,185 ±  340  47,345 ±  1,545  80,295 ±  13,420 
13  [Asn 1, Phe(4-NH2)S]-AI[  1,505 ::1:52  158,177:1:19,841  9,256 ± 338  ND:~  15,696 ±  290  31,239 ±  1,415 
* Same as Table 1. 
:~ Not determined. 
TABLE V 
Antigen±city and Immunogenicity of AH Analogues in  Which  Tyr  4 and Phe 8 Are Replaced by Phe(4-N02) 
Guinea 
pig 
strain 
Immunized 
[SHITdR antigen in culture* 
None  PPD  All 
[Asn',  [Asn ~, 
Phe(4-NO2)%AII  Phe(4-NO~)S]-AIl 
cpm  cpm  cpm 
2  All  841 ±  61  122,786 ±  1,416  21,026 +  401  812 ±  127  850 ±  105 
2  [Asn ~, Phe(4-NO.z)4]-AII  2,958 ±  41  150,191  ±  9,480  5,720 ±  760  111,630 ±  6,388  23,830 ±  1,005 
2  [Asn 1, Phe(4-NO2)%AII  3,184 +  236  198,244 ±  2,650  30,456 ±  1,363  4,648 ±  627  28.010 +  653 
13  [Asn ~, Phe(4-NO~)4]-AII  1,549 ±  30  140,908 ±  4,046  2,026 ±  244  53,412 +  2,771  10,909 ± 336 
13  [Asn ~, Phe(4-NO~)%AI1  442 ±  37  105,573 ±  2,353  3,196 ± 272  7,677 ±  150  17,142 ±  517 
* Same as Table I. 
[Asnl,Phe(4-NH2)4]-AII,  [Asnl,Phe(4-NH2)6]-AII, or [AsnX,Phe(4-NH2)S]-AII, indicat- 
ing that these substitutions altered antigen±city. On the other hand, strain 2 T  cells 
immunized with  [Asnl,Phe(4-NH2)4]-AII  were responsive with the immunizing ana- 
logue but were unresponsive with All,  [Asnl,Phe(4-NH2)6]-AII,  and [Asnl(4-NH2)S] - 
All.  [Asnl,Phe(4-NH2)6]-AII  and [Asnl,Phe(4-NH2)S]-AII  were  nonimmunogenic for 
strain  2  guinea  pigs  and  failed  to  prime  for  responsiveness  to  All.  In  contrast, 
immunization  of strain  13  animals  with  the same  analogues  produced  a  reciprocal 
pattern of responsiveness.  [Asnl,Phe(4-NH2)4]-AII was nonimmunogenic in strain  13, 
whereas  immunization with [Asnl,Phe(4-NH2)6]-AII  and [Asnl,Phe(4-NH2)S]-AII  re- 
sulted in good T  cell responses.  However, T  cells from strain  13 animals immunized 
with  these  latter  two  analogues  showed  considerable  cross-reactivity.  Some  cross- 
reactivity was  also observed with All  after  immunization with  [Asn2,Phe(4-NH2)S]- 
All. 
A  second set  of analogues  in which Tyr  4 and  Phe  s were  substituted with  Phe(4- 
NO2)  instead of Phe(4-NH2),  as above, also produced a  distinct  pattern of strain  2 
and strain 13 T  cell responses (Table V). Strain 2 All-immune T  cells were unrespon- 
sive with  [Asnl,Phe(4-NOz)4]-AII  and [Asnl,Phe(4-NO2)S]-AII,  again indicating that 
these  substitutions  altered  the  antigen±city  of All.  T  cells  from  strain  2  animals 
immunized with [Asnl,Phe(4-NO2)4]-AII responded with [Asnl,Phe(4-NO2)4]-AII and 
showed 20% cross-reactivity with [Asnl,Phe(4-NO2)S]-AII, but were unresponsive with 588  FINE  SPECIFICITY OF  Ir GENE  CONTROL 
AII.  [Asnl,Phe(4-NOz)S]-AII-immune strain  2 T  cells were equally responsive with 
both  [Asnl,Phe(4-NOz)8]-AII  and  All,  but  were  unresponsive  with  [Asnl,Phe(4  - 
NO2)4]-AII.  Immunization  of strain  13  guinea  pigs  with  [Asnl,Phe(4-NOz)4]-AII 
resulted  in  T  cell  responses  with  [Asnl,Phe(4-NOz)4]-AII  and  showed  20%  cross- 
reactivity with [Asnl,Phe(4-NO2)a]-AII, but were unresponsive with All. [Asnl,Phe(4  - 
NOz)8]-AII-immune  strain  13  T  cells  responded  with  [AsnX,Phe(4-NO2)8]-AII  and 
produced 45% cross-reactivity with [Asnl,Phe(4-NO2)4]-AII and 20% cross-reactivity 
with All. This pattern of cross-reactivity with All and [Asna,Phe(4-NO2)4]-AII after 
immunization of strain 13 with [AsnX,Phe(4-NOz)a]-AII is clearly much different from 
that obtained in strain 2 guinea pigs. These results indicate that although both strain 
2  and  strain  13  animals  respond  to  the  same  octapeptide  antigen,  [Asnl,Phe(4  - 
No2)s]-AII may be recognized differently by strain 2 and strain  13 T  cells.  It should 
be noted that T  cell responses to Phe(4-NHz)-containing analogues were non-cross- 
reactive with Phe(4-NOz)-containing analogues and vice versa (data not shown). 
A number of other AII analogues primarily containing substitutions for Phe  8 were 
examined for antigenicity and immunogenicity in strain 2 and strain  13 guinea pigs 
and were found to be nonimmunogenic (summarized in Fig.  1). These results indicate 
that the carboxyl terminal residue is important for T  cell responses and suggest that 
aromaticity in this position is required. However, it should be noted that removal of 
this residue, as in the analogue [AcAsnl,ValS,des-PheS]-AII, restores immunogenicity 
in strain  13, but not in strain 2 guinea pigs. 
Discussion 
In  this  study  we  have  examined  the  specificity of Ir  gene  control  and  T  cell 
recognition of a series of small peptide antigens based on the octapeptide, angiotensin 
II. A summary of strain 2 and strain  13 guinea pig T  cell responses to these antigens 
is shown in Fig.  1. It is clear that nearly all modifications of AII, either single residue 
substitutions or alterations in peptide length, have a dramatic effect on Ir gene control 
and/or T  cell recognition. The fact that  most of these changes result in all-or-none 
effects on T  cell responses suggests that the overall response is probably restricted to 
several clones. In addition, the small size of these peptide antigens seems to severely 
restrict potential immunocompetent cellular interactions. For these reasons, we feel 
that  the  observed  responses  are  representative  of T  cell  recognition  of antigen 
presented  by  stimulator  cells  and  may  not  involve  more  complicated  regulatory 
mechanisms. In most of these cases, it appears that Ir gene control and the specificity 
of T  cell responses are linked, but there are situations in which specificity and Ir gene 
control  are  to  some  extent  independently  coordinated.  The  discussion  below  will 
therefore treat  Ir gene control and  T  cell specificity separately, and  then compare 
both aspects to develop a model for T  cell recognition. 
Specificity of Ir Gene Control.  One of the most striking features of the AII antigen 
system  is  the  exquisite  specificity of Ir  gene  control  of T  cell  responsiveness,  as 
summarized in Fig.  1.  For example, strain  2 guinea pigs respond to AII and show 
little responsiveness to  [ValS]-AII, whereas strain  13 animals  respond  to  [ValS]-AII 
and  not  to  AII.  Therefore,  Ir gene  control  of responsiveness  in  this  situation  is 
regulated by the single methyl-group difference between Val  5 and Ile  ~. Based on this 
observation,  it  was  anticipated  that  strain  2  animals  would  respond  to  any  AII 
analogue containing Ile  5 and  strain  13 would respond to any analogue containing THOMAS, HSIEH, SCHAUSTER, AND WILNER  589 
Val  5. This was not observed, however, and regulation of responsiveness by the fifth 
residue in AII also involved the amino terminal residue. Thus, strain  13 guinea pigs 
failed to respond to [VaI4]-AIII, but responded to [Ile4]-AIII. In this case, the presence 
or absence of Asp 1 must  also be involved in strain  13 responsiveness to AII.  These 
results suggest that no one peptide residue determines Ir gene control, but that genetic 
control of responsiveness relates to the overall structure of the peptide antigen. This 
implies that each peptide analogue may represent a distinct antigenic species, respon- 
siveness to which cannot be predicted based on responses to closely related antigens. 
The  other  examples  of the  specificity of Ir  gene  control  are  shown  with  AII 
analogues in which Tyr  4 and Phe  s have been substituted with Phe(4-NH2) or Phe(4- 
NO2).  Strain  13 guinea pigs respond to [Phe(4-NO2)4]-AII but  are unresponsive to 
[Phe(4-NH2)4]-AII, and  strain  2  animals  respond to both analogues.  On  the other 
hand,  strain  2  guinea  pigs  respond  to  [Phe(4-NO~)S]-AII  and  are  unresponsive  to 
[Phe(4-NH2)S]-AII, whereas strain 13 animals respond to both analogues. These results 
provide  further  evidence  that  the  genetic  control  of T  cell  responsiveness  shows 
extremely fine specificity and  can  discriminate  between subtle changes  in  the  AII 
residues. 
Specificity of T  Lymphocyte Recognition.  In  a  previous study of T  cell responses to 
human fibrinopeptide B and closely related analogues, we found that several residues 
determined the clonal specificity of T  cell responses (3). Similarly, with AII we found 
residues that seemed to be critical for the specificity of T  cell responses. In strain  2 
guinea  pigs,  for  example,  substitutions  of Phe(4-NH2)  and  Phe(4-NO2)  for  Tyr  4 
resulted in analogues that elicited unique non-cross-reactive T  cell responses, indicat- 
ing that Tyr  4 may make a major contribution to the specificity of antigen recognition. 
A similar analysis in strain  13 animals cannot be made because these same substitu- 
tions determined responsiveness or unresponsiveness. However, substitutions of Phe(4- 
NH2) or Phe(4-NO2) for Phe  s resulted in unique non-cross-reactive T  cell responses in 
strain  13  animals.  Again,  a  similar  analysis  cannot  be  made  in  strain  2  animals 
because these substitutions  determine responsiveness. As discussed previously, Asp 1 
does not seem to be involved in specificity because Asn 1 is interchangeable with Asp ~. 
Thus, the specificity of T  cell responses can be altered by substitutions for Tyr  4, His  6 
(in strain  13), and Phe  s. 
Comparisons of Ir  Gene Control and  T  Lymphocyte Recognition.  It  is  clear  from  the 
preceding discussion  that  Ir gene control of T  cell responses to the AII antigens  is 
highly specific and  may involve multiple interactions with  the peptide.  Moreover, 
several residues were identified that seemed to be important for both the specificity 
and genetic control of T cell responses. These observations suggest that Ir gene control 
and  T  cell  recognition of antigen  may be  intimately associated.  One of the  more 
striking observations derived from the antigen survey shown in Fig.  1 is the pattern of 
strain  2 and strain  13 responses.  In general, strain  2 and  strain  13 animals  do not 
respond to the same peptide antigens.  In  fact, out  of 37 peptide antigens we have 
examined  thus  far  in  several  systems,  strain  2  and  strain  13  guinea  pigs  rarely 
responded to the same peptide. The exceptions to this observation are T cell responses 
to  [Phe(4-NO2)4]-AII and  [Phe(4-NO2)S]-AII.  However, [Phe(4-NO2)S]-AII-immune 
strain 2 T  cells show total cross-reactivity with AII and are unresponsive with [Phe(4- 
NO2)4]-AII, whereas immune strain  13 T  cells show the reciprocal pattern of cross- 
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No2)s]-AII, the  antigen  is  probably recognized differently. These results,  although 
limited, suggest  that  the expression of the antigen-combining repertoire of strain  2 
and strain 13 T  cells is generally nonoverlapping. This implies that T  cells from these 
two strains rarely recognize an antigen in precisely the same manner. This difference 
may never be seen using larger proteins that contain a variety of antigenic determi- 
nants,  but it is obvious when examining responses to small peptides that  limit  the 
number of available antigenic determinants. This point is of considerable importance 
and will be considered later in developing a model for T  cell recognition. 
The other important point made in this survey is that there are many "holes" in T 
cell responses to closely related peptide analogues. In many of these cases responsive- 
ness  fluctuates between  strain  2  and  strain  13  guinea  pigs.  However, the  residues 
regulating responsiveness may serve more than one function. For example, in strain 
2 guinea pigs substitutions for Tyr  4 alter the specificity of the T cell response, whereas 
in strain 13 they determine responsiveness or unresponsiveness. Similarly, substitutions 
for Phe  8 determine the specificity of strain  13 T  cell responses, whereas in strain  2 
they determine responsiveness. Thus, there are situations in which residue substitutions 
alter the specificity of the T  cell response without changing Ir gene control (3), and 
situations where specificity and Ir gene control are both changed. These observations 
may be  due  to  the  apparent  nonoverlap of strain  2  and  strain  13  T  cell  antigen 
recognition, because each residue may serve a different function in responses by both 
strains. 
Comparisons of T  Lymphocyte Responses ~bith Antibody and Hormone Activity  of AII.  As 
indicated in the introduction, angiotensin has been widely used to examine antibody 
binding using the same approach employed here to investigate T  cell responses. In 
addition, a  number of studies have been performed to determine the parameters of 
AII binding to the hormone receptor (11).  It is therefore of interest to compare our 
findings concerning T  cell responses with those measuring AII reactivity using these 
other  types  of receptors.  Briefly,  AII  binding  by  rabbit  anti-AII  antibody  was 
substantially reduced only by residue substitutions for Phe  s, Pro  7, Tyr  4, and to a lesser 
extent His  8 (4).  For biological activity, the most important residues were Phe  8, Pro  7, 
His  6,  Tyr  4,  and  Arg  2  (11).  It  is  clear  from  these  analyses  that  guinea  pig  T  cell 
responses are dependent on two residues that are less critical for antibody or hormone 
receptor binding, Asp 1 and Ile  s. This suggests that AII recognition by guinea pig T 
cells is different from AII binding by rabbit antibody or the hormone receptor. 
Implications for Antigen  Binding by T  Cells.  The observation that T  cell recognition 
of AII seems to be more complex than other highly specific AII receptors implies that 
the antigen combining site for AII in T  cell responses must be somewhat rigid, with 
well-defined spatial and contact parameters. The formation of such a  receptor must 
also take into account the observations for Ir gene control, which indicate that  the 
antigen-combining repertoire of strain 2 and strain 13 T  cells appears to be generally 
exclusive. As demonstrated previously, the differences in the genetic control of immune 
responses  are  determined  by  the  expression  of macrophagelike  stimulator  cell  Ia 
antigens  (2,  12-16).  Therefore,  considerations  for  antigen  recognition  in  T  cell 
responses must  take  into account both  the antigen-combining capacity of T  cells, 
presumably effected through a clonally distributed receptor, and the involvement of 
stimulator cell Ia antigens. The simplest explanation would be that the difference in 
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T  cell antigen-combining receptor. Thus, the genetic basis for T  cell diversity would 
be due to different variable-like regions in strain 2 and strain  13 T  cell receptors. In 
this case, Ia may serve only as a  second signal to affect T  cell activation, and/or Ia 
may serve to select particular variable-like regions expressed by T  cells.  However, it 
is difficult to imagine that the variable-like region genes would be exclusive in strain 
2 and strain  13 T  cells, or that Ia could "pick out" closely related variable-like region 
genes to be expressed, particularly in view of the fine antigenic distinctions demon- 
strated in anti-AII T  cell responses. 
A more likely possibility is that the repertoire of variable-like region genes for T cell 
receptors is similar in strain 2 and strain  13 guinea pigs.and that stimulator cell Ia 
antigens are involved in the specificity of the response at the time of antigen exposure. 
Again, the specificity of Ir gene control strongly suggests an intimate involvement of 
Ia antigens in the recognition of exogenous antigens, probably in conjunction with 
the antigen-combining T  cell receptor. There are two types of models that  would 
accommodate all of the observations made here. The first is the determinant selection 
model proposed by Rosenthal  (17) and Benacerraf (18).  According to this model, Ia 
antigens show discriminating antigen-combining properties and bind antigen before 
interaction with T cells. Because different Ia molecular species bind different antigenic 
determinants, distinct determinants are available for T  cell recognition. Based on the 
data presented here, this model would suggest that Ia antigens show very fine antigen- 
combining properties that could distinguish Val  5 from Ile  5, for example. In addition, 
we observed nine situations in which genetic control fluctuated between strain 2 and 
strain  13 T  cell responses to closely related peptides, which, according to this model, 
would imply a  minimum of nine different Ia molecular species for the All antigens 
tested  thus  far.  Although  biochemical  analyses  have  indicated  that  guinea  pig  Ia 
antigens are fairly homogeneous (19), complete residue sequences will be required to 
establish their degree of heterogeneity. 
A  second model, as we proposed before (3), is that  the antigen-combining site is 
formed by the physical interaction between the T  cell receptor and stimulator cell Ia 
antigens, similar to heavy and light chain interactions in immunoglobulins. This Ia- 
T  cell  receptor interaction  defines  the  spatial  and  contact  parameters  within  the 
newly  formed  antigen-combining  site  and  thus  creates  the  specificity  of T  cell 
recognition and Ir gene control. Much of the contact specificity would be contributed 
by  clonally  expressed  T  cell  receptors,  whereas  stimulator  cell  Ia  antigens  may 
primarily stabilize the T  cell receptor and  determine the spatial  constraints of the 
combining site. Ia molecules might also provide some limited contact sites for antigen, 
but this may depend on the particular antigen and how it is accommodated in the 
combining site.  In contrast to the determinant selection model, this model predicts 
that antigen will only be bound after stabilization of the combining site by the Ia-T 
cell receptor interaction. 
Both  models  suggest  that  the  basis  for genetic  restrictions  between  T  cells  and 
stimulator cells is simply clonal selection for T  cells with different antigen-combining 
properties,  similar  to  selecting  T  cells  that  distinguish  ovalbumin  from  human 
gammaglobulin,  and  that  there is  no  inherent  Ia  restriction distinct  from antigen 
recognition.  In  addition,  the  final  recognition  complex,  once  formed,  would  be 
identical  according  to  both  models.  However,  it  may  be  possible  to  distinguish 
between these models experimentally by using the AII antigen system described here. 592  FINE SPECIFICITY OF Ir GENE CONTROL 
One prediction of the determinant selection proposal is that strain 2 and strain  13 Ia 
molecules would  contact  the  residue  determining  genetic  control,  e.g.,  strain  2  Ia 
contacts Ile  5 and strain 13 Ia contacts Val  5, thus leaving similar antigenic determinants 
free to  interact  with  strain  2  and  strain  13  T  cells.  Thus,  T  cells  from  (2  ×  13)F1 
animals  immunized  with  AII  would  be  expected  to  respond  not  only  to  AII  in 
association with strain 2 stimulator cells, but also with [ValS]-AII in association with 
strain 13 stimulator cells. According to our alternative model, AII-immune (2 ×  13)F1 
T  cells would respond only to AII associated with strain 2 stimulator cells, and not to 
any AII analogue or homologue with strain  13 stimulator cells, because much of the 
specificity of Ir gene control would reside with the T  cell antigen combining receptor 
in this case. These and related experiments should provide useful information toward 
our understanding of T  cell recognition of antigen and the role of Ia antigens in this 
process. 
Summary 
Guinea pig T  lymphocyte responses to the octapeptide antigen angiotensin II (NH2- 
Aspl-Arg2-Val3-Tyr4-Ile~-His6-Pro7-PheS-OH; AII) were examined using various syn- 
thetic  peptide  analogues  and  homologues.  Each  peptide  antigen  was  assessed  for 
immunogenicity and antigenicity in strain 2 and strain  13 guinea pigs as determined 
by in vitro T  cell proliferative responses. The genetic control of T  cell responses to 
these peptides was found  to be highly specific and capable of distinguishing  subtle 
differences in the antigens.  For example, strain  2 guinea pigs responded to AII and 
were low responders to [ValS]-AII, whereas strain  13 animals responded to [ValS]-AII 
but not to AII. The genetic control in this case involved the difference of one methyl 
group  between  Val  5 and  Ile  ~.  Differences in  T  cell  responsiveness by strain  2  and 
strain  13 guinea pigs were also observed with analogues involving para substitutions 
on the phenyl ring of Tyr  4 and  of Phe  s.  However, the genetic regulation  of T  cell 
responses did not seem to be based on a single peptide residue. For example, removal 
of Asp  1 allowed  strain  13  animals  to  respond  to  the  IleS-containing analogue,  but 
eliminated  responsiveness to the ValS-containing analogue.  Thus, the first and fifth 
AII  residues  are  both  involved  in  the  regulation  of  strain  13  T  cell  responses. 
Substitutions for Tyr  4 and Phe  s suggested that the same residue may serve to alter the 
specificity of T  cell responses in one strain, and determine responsiveness or unrespon- 
siveness  in  the  other  strain.  One  of the  most  striking  observations  is  that  T  cell 
responsiveness  to  the  various  AII  analogues  and  homologues  randomly  fluctuates 
between strain 2 and strain  13 guinea pigs, and in general neither strain responds to 
the same peptide antigens. This suggests that strain 2 and strain  13 T  cell responses 
are  rarely  directed  against  the  same  antigenic  determinants,  and  that  the  T  cell 
antigen-combining  diversity  is  usually  exclusive  between  these  two  strains.  These 
results  are  discussed  with  respect  to  the  specificity  of  Ir  gene  control  and  the 
relationship between Ir gene function and antigen recognition by T  cells. 
Note added in proof: More  recent  experiments using  a  new  lot  of [Val5]-AII have 
indicated  that  [ValS]-AII-immune strain 2 T  cells show significant stimulation with 
AII but remain relatively low responders with  [ValS]-AII, as shown in Table I. The THOMAS, HSIEH, SCHAUSTER,  AND WILNER  593 
difference in priming for cross-reactivity for AII with the different  lots of [ValS]-AII 
is at present  unknown. 
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